Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of OIF/KX (recombinant human BMP-2) for long-bone nonunion surgery
jRCT2080225010Phase 2Completed
- Sponsor
- Osteo-Pharma
- Start
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dibotermin alfa in pseudoarthrosis, sponsored by Osteo-Pharma. Started Jan 2020; status: completed.
02
Drugs
dibotermin alfa
03
Conditions
pseudoarthrosis
Beyond the preview
Go deeper on jRCT2080225010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225010.